We were interested to read the paper by Sugimura et al, which evaluated the safety and efficacy of breast milk eye drops in infants up to six months of age with eye discharges. The authors reported that they found these as effective as sodium azulene sulphonate hydrate 0.02% and noted that eye discharge improved in 76.8% of patients without any adverse events. Although these results seem to be promising, we believe that there are some issues that warrant further clarification.
